Legal & General Group
HUMA icon

Legal & General Group’s Humacyte HUMA Stock Holding History

Legal & General Group’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,022
Closed -$9.11K – 3465
2026
Q1 		$9.11K Sell
15,022
-595
-4% -$619 ﹤0.01% 3200
2025
Q4 		$15K Buy
15,617
+3,608
+30% +$5.11K ﹤0.01% 3130
2025
Q3 		$20.9K Hold
12,009
– – ﹤0.01% 3016
2025
Q2 		$25.1K Sell
12,009
-79,838
-87% -$153K ﹤0.01% 2915
2025
Q1 		$157K Buy
91,847
+10,442
+13% +$39.2K ﹤0.01% 2640
2024
Q4 		$411K Buy
81,405
+13,293
+20% +$65.8K ﹤0.01% 2530
2024
Q3 		$371K Buy
68,112
+58,377
+600% +$385K ﹤0.01% 2559
2024
Q2 		$46.7K Buy
9,735
+3,928
+68% +$20.4K ﹤0.01% 2807
2024
Q1 		$18.1K Sell
5,807
-767
-12% -$2.58K ﹤0.01% 3007
2023
Q4 		$18.7K Sell
6,574
-641
-9% -$1.65K ﹤0.01% 3059
2023
Q3 		$21.1K Buy
7,215
+410
+6% +$1.36K ﹤0.01% 3003
2023
Q2 		$19.5K Sell
6,805
-251
-4% -$905 ﹤0.01% 3124
2023
Q1 		$21.8K Sell
7,056
-13,610
-66% -$38.7K ﹤0.01% 3043
2022
Q4 		$43.6K Buy
20,666
+5,167
+33% +$15.7K ﹤0.01% 2970
2022
Q3 		$51K Sell
15,499
-1,471
-9% -$5.64K ﹤0.01% 2969
2022
Q2 		$55K Buy
16,970
+3,364
+25% +$18.7K ﹤0.01% 2991
2022
Q1 		$96K Hold
13,606
– – ﹤0.01% 2880
2021
Q4 		$99K Buy
+13,606
New +$135K ﹤0.01% 2910

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Legal & General Group's HUMA Position: Q2 2026 in Review

Legal & General Group sold out of Humacyte (HUMA) in Q2 2026, closing a stake of 15,022 shares — an estimated $9.11K sold.

Legal & General Group first reported a position in HUMA in Q4 2021 and held it in 18 quarters. The position peaked at $411K in Q4 2024. 163 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Legal & General Group reported no remaining Humacyte position as of Q2 2026 after selling out during the quarter.
  • Legal & General Group sold 15,022 Humacyte shares in Q2 2026, an estimated $9.11K.
  • Legal & General Group first reported a position in Humacyte in Q4 2021 and held it in 18 quarters.
  • Legal & General Group's Humacyte position peaked at $411K in Q4 2024.
  • 163 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.